Literature DB >> 1849852

Liver atrophy after transcatheter arterial embolization and percutaneous ethanol injection therapy for a minute hepatocellular carcinoma.

Y Motoo1, T Okai, O Matsui, H Ohta, N Sawabu.   

Abstract

A 63-year-old male patient with compensated cirrhosis underwent transcatheter arterial embolization (TAE) and percutaneous ethanol injection therapy (PEIT) for a minute hepatocellular carcinoma (HCC). Although the HCC was successfully treated, esophageal varices worsened and refractory ascites developed 3 months after the TAE and PEIT. Liver atrophy progressed rapidly compared to the natural course of liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849852     DOI: 10.1007/bf01887335

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN: 0364-2356


  8 in total

1.  [A case of hepatocellular carcinoma treated by the combined therapy of ultrasonic guided ethanol injection and transcatheter arterial embolization].

Authors:  Y Suyama; M Horishi; S Ebisui; Y Shisumi; T Maekawa; H Fujii; M Miyoshi
Journal:  Gan No Rinsho       Date:  1989-02

2.  [Evaluation of portal hemodynamic changes after transcatheter hepatic arterial embolization].

Authors:  S Hirota; K Okuda; M Sako; T Shimizu; M Hasegawa; K Tanaka; M Hase; M Kono
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1988-02-25

3.  [Necrotizing effect of the combination therapy of TAE and PEIT on advanced hepatocellular carcinoma].

Authors:  J Satoi; S Morimoto; K Komiyama; R Ogawa; A Kanezaki; Y Tsuboi; T Ui; Y Mase; K Nagayama; T Tanaka
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1988-09

4.  [Study of percutaneous ethanol injection therapy (PEIT) under ultrasonography in hepatocellular carcinoma].

Authors:  K Notsumata; M Shimizu; M Unoura; Y Mizuno; H Rhorin; Y Motoo; K Kobayashi; N Hattori; O Matsui; R Izumi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1988-12

5.  Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma.

Authors:  K Hirai; Y Kawazoe; K Yamashita; Y Aoki; T Fujimoto; T Sakai; Y Majima; M Abe; K Tanikawa
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and risk factors.

Authors:  K Takayasu; M Suzuki; K Uesaka; Y Muramatsu; N Moriyama; T Yoshida; M Yoshino; N Okazaki; H Hasegawa
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Transcatheter oily chemoembolization of hepatocellular carcinoma.

Authors:  H Nakamura; T Hashimoto; H Oi; S Sawada
Journal:  Radiology       Date:  1989-03       Impact factor: 11.105

8.  Small hepatocellular carcinoma: percutaneous alcohol injection--results in 23 patients.

Authors:  T Livraghi; A Salmi; L Bolondi; G Marin; V Arienti; F Monti; C Vettori
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

  8 in total
  1 in total

1.  Radiofrequency thermal ablation with expandable needle of focal liver malignancies: complication report.

Authors:  Elisabetta Buscarini; Luigi Buscarini
Journal:  Eur Radiol       Date:  2003-10-17       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.